Is Bruker Corporation a good dividend stock?

Bruker Corporation (BRKR) is a dividend-paying stock with a current dividend yield of 0.33%. Review its dividend history, payout consistency and growth to judge whether it fits your income strategy.

What is BRKR's dividend yield?

The dividend yield for BRKR stock is currently 0.33%.

How much does BRKR pay in dividends per year?

Bruker Corporation pays an annual dividend of $0.2000 per share over the trailing twelve months.

How often does BRKR pay dividends?

BRKR stock pays dividends quarterly.

Is BRKR's dividend growing?

Bruker Corporation's 3-year dividend CAGR is 0%.

BRKR Stock Price, Chart, Stats & News

Bruker Corporation

Save

Overview Dividend safety Dividends Fundamentals

Bruker Corporation (BRKR) is a dividend-paying stock with a current dividend yield of 0.33% as of Jul 14, 2026. It pays $0.2000 per share over the trailing twelve months and distributes quarterly. Its dividend has grown at a 4.56% 5-year compound annual rate.

9.11B

Market cap

32.87x

Current P/E

15.22x

Forward P/E

0.33%

Dividend yield

$0.2000

BRKR dividend

Dividend safety

Strong

Dividend coverage looks healthy — BRKR pays out about 11% of earnings.

See the safety analysis

BRKR chart

Loading chart...

Fundamentals

Gross margin	46.62%
Operating margin	5.44%
Pretax margin	0.61%
Net margin	-0.25%
Effective tax rate	139.52%
ROA	-0.14%
ROE	-0.40%
D/E	0.83x
Interest coverage ratio	3.27x

All financials

BRKR valuation

P/E	32.87x
P/S	1.49x
P/B	2.09x
P/CF	38.22x
P/FCF	118.54x
P/OCF	38.22x
PEG	-95.36x
EV multiple	11.40x

About

Bruker Corporation stands as a prominent global developer, manufacturer, and distributor of cutting-edge scientific instruments, alongside comprehensive analytical and diagnostic solutions. Its operations are structured across three distinct segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. The company's extensive portfolio for life sciences encompasses a variety of advanced tools, including single and multi-modality systems, sophisticated mass spectrometry platforms, and critical diagnostic solutions.